APOE and coronary artery disorder: Smoking interacts with ApoE genotype to amplify CV risk, particularly among ε4 carriers, who experience a greater increase in coronary heart disease (CHD) and mortality compared to non-carriers; this effect is especially pronounced in women and current smokers, but risk decreases with smoking cessation [35,36,37].